EP3471562A4 - Compositions synthétiques comprenant des oligosaccharides du lait humain pour l'utilisation dans la prévention et le traitement de troubles - Google Patents

Compositions synthétiques comprenant des oligosaccharides du lait humain pour l'utilisation dans la prévention et le traitement de troubles Download PDF

Info

Publication number
EP3471562A4
EP3471562A4 EP17812794.0A EP17812794A EP3471562A4 EP 3471562 A4 EP3471562 A4 EP 3471562A4 EP 17812794 A EP17812794 A EP 17812794A EP 3471562 A4 EP3471562 A4 EP 3471562A4
Authority
EP
European Patent Office
Prior art keywords
disorders
prevention
treatment
human milk
milk oligosaccharides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17812794.0A
Other languages
German (de)
English (en)
Other versions
EP3471562A1 (fr
Inventor
Louise Kristine VIGSNÆS
Bruce Mcconnell
Emma ELISON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glycom AS
Original Assignee
Glycom AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/183,431 external-priority patent/US10987368B2/en
Priority claimed from US15/183,391 external-priority patent/US10835544B2/en
Priority claimed from US15/183,404 external-priority patent/US10881674B2/en
Application filed by Glycom AS filed Critical Glycom AS
Publication of EP3471562A1 publication Critical patent/EP3471562A1/fr
Publication of EP3471562A4 publication Critical patent/EP3471562A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP17812794.0A 2016-06-15 2017-06-15 Compositions synthétiques comprenant des oligosaccharides du lait humain pour l'utilisation dans la prévention et le traitement de troubles Withdrawn EP3471562A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15/183,431 US10987368B2 (en) 2014-12-08 2016-06-15 Synthetic composition for preventing or treating CVD
US15/183,391 US10835544B2 (en) 2014-12-08 2016-06-15 Synthetic composition for regulating satiety
US15/183,404 US10881674B2 (en) 2014-12-08 2016-06-15 Synthetic composition for treating metabolic disorders
PCT/DK2017/050198 WO2017215721A1 (fr) 2016-06-15 2017-06-15 Compositions synthétiques comprenant des oligosaccharides du lait humain pour l'utilisation dans la prévention et le traitement de troubles

Publications (2)

Publication Number Publication Date
EP3471562A1 EP3471562A1 (fr) 2019-04-24
EP3471562A4 true EP3471562A4 (fr) 2020-07-29

Family

ID=60663363

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17812794.0A Withdrawn EP3471562A4 (fr) 2016-06-15 2017-06-15 Compositions synthétiques comprenant des oligosaccharides du lait humain pour l'utilisation dans la prévention et le traitement de troubles

Country Status (2)

Country Link
EP (1) EP3471562A4 (fr)
WO (1) WO2017215721A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021094993A1 (fr) * 2019-11-14 2021-05-20 Glycom A/S Composition synthétique pour équilibrer le profil d'acides biliaires dans l'intestin
WO2021123253A1 (fr) * 2019-12-19 2021-06-24 Basf Se Composition pour le traitement de la (pré)hyperglycémie et/ou de morbidités associées à cette dernière
ES2981224T3 (es) * 2020-01-31 2024-10-07 N V Nutricia Composición nutricional para su uso en la maduración intestinal
AU2021241800A1 (en) * 2020-03-25 2022-08-04 Frieslandcampina Nederland B.V. Compositions comprising one or more HMO's with a core of LacNac-Lac
TW202233201A (zh) * 2020-12-16 2022-09-01 荷蘭商弗里斯蘭康必奶荷蘭有限公司 包含ＬＮＦＰ ＩＩＩ和ＬＳＴａ的合成組成物
CN114145353A (zh) * 2021-11-30 2022-03-08 内蒙古伊利实业集团股份有限公司 一种可改善肠道微环境健康的配方奶粉及其制备方法与应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
PL1962823T3 (pl) * 2005-12-23 2015-08-31 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka i mangan i/lub molibden do poprawy składu błony komórkowej
EP2072052A1 (fr) * 2007-12-17 2009-06-24 Nestec S.A. Prévention d'infections opportunistes dans des sujets dont l'immunité est fragilisée
ES2611203T3 (es) * 2007-12-21 2017-05-05 N.V. Nutricia Uso de esfingomielina y carbohidratos no digeribles para mejorar la microbiota intestinal
WO2011119023A1 (fr) * 2010-03-26 2011-09-29 N.V. Nutricia Formule pour nourrisson à faible teneur en protéine dotée d'acides aminés essentiels accrus
RU2604503C2 (ru) * 2011-10-18 2016-12-10 Нестек С.А. Композиция для применения при повышении чувствительности к инсулину и/или снижении инсулинорезистентности
PL2999358T3 (pl) * 2013-05-22 2021-12-20 Glycom A/S Syntetyczna mieszanina oligosacharydów do leczenia mikrobioty ssaka
US20150305385A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
CN107106584A (zh) * 2014-12-08 2017-08-29 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
AU2017101896A4 (en) * 2016-01-26 2021-02-04 Société des Produits Nestlé S.A. Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing GLP-1 secretion
AU2017211272B2 (en) * 2016-01-26 2022-04-21 Société des Produits Nestlé S.A. Human milk oligosaccharides for health benefits by prevention of premature adiposity rebound
MX2018009016A (es) * 2016-01-26 2018-09-28 Nestec Sa Composiciones que comprenden oligosacaridos sialilados para usar en infantes o niños pequeños para prevenir la obesidad mas adelante en la vida o comorbilidades relacionadas y promover un crecimiento sano.
EP3407894A1 (fr) * 2016-01-26 2018-12-05 Nestec S.A. Compositions comprenant 2 fl et lnnt pour utilisation chez des nourrissons ou de jeunes enfants pour prévenir ultérieurement dans la vie l'obésité ou des comorbidités associées

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
WO2017215721A1 (fr) 2017-12-21
EP3471562A1 (fr) 2019-04-24

Similar Documents

Publication Publication Date Title
EP3675882A4 (fr) Methodes et compositions pour le traitement de troubles associés au microbiome
IL298689B1 (en) Preparations and methods for suppressing masp-3 for the treatment of various diseases and conditions
EP3448398A4 (fr) Compositions et méthodes pour le traitement de troubles cutanés
EP3370748A4 (fr) Microbiote thérapeutique pour le traitement et/ou la prévention de l'allergie alimentaire
PT3377637T (pt) Composições para uso em métodos para o tratamento de ferimentos, transtornos e doenças da pele
EP3621973A4 (fr) Composés pour la prévention et le traitement de maladies et leur utilisation
EP3471562A4 (fr) Compositions synthétiques comprenant des oligosaccharides du lait humain pour l'utilisation dans la prévention et le traitement de troubles
EP3405215A4 (fr) Méthodes destinées au traitement de la maladie de danon et d'autres troubles liés à l'autophagie
ZA202002066B (en) Compositions and methods for the treatment of eye disorders
EP3639833A4 (fr) Agent pour la prévention ou le traitement de maladies liées à la graisse et/ou de l'inflammation
EP3558279A4 (fr) Compositions et méthode s pour le traitement d'une douleur chronique
EP3277287B8 (fr) Mélange d'oligosaccharides de lait humain comprenant du 3'-o-sialyllactose
EP3352749A4 (fr) Composés et compositions pour le traitement de troubles oculaires
IL263477A (en) Compositions and methods for the treatment or prevention of oxalate-related disorders
EP3261446A4 (fr) Méthodes et compositions permettant le traitement ou la prévention de la maladie de parkinson
IL272097A (en) Compounds for the prevention and treatment of medical disorders and their uses
EP3506899A4 (fr) Compositions et méthodes de diagnostic et de traitement de troubles du système lymphatique
IL269400A (en) Medicines and preparations for the treatment of eye disorders
EP3856147A4 (fr) Méthodes et compositions probiotiques destinées au traitement de lésions osseuses
EP3119387A4 (fr) Compositions pour le traitement de maladies et de troubles dermatologiques
EP3518951A4 (fr) Compositions et méthodes pour le traitement d'affections orthopédiques
EP3452169A4 (fr) Méthodes et compositions pour le traitement et/ou la prévention de troubles associés au sang
EP3846851A4 (fr) Compositions et procédés pour le diagnostic et le traitement de troubles du système lymphatique
EP3568138A4 (fr) Compositions et méthodes pour le traitement de maladies ou de troubles associés à la myéline et à une inflammation
EP3534924A4 (fr) Composition pour la prévention et/ou le traitement de maladies cardiovasculaires

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190115

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/702 20060101ALI20200123BHEP

Ipc: A61P 3/04 20060101ALN20200123BHEP

Ipc: A23L 33/125 20160101AFI20200123BHEP

Ipc: A61P 3/10 20060101ALN20200123BHEP

Ipc: A61P 9/10 20060101ALN20200123BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20200626

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 9/10 20060101ALN20200622BHEP

Ipc: A61P 3/04 20060101ALN20200622BHEP

Ipc: A61P 3/10 20060101ALN20200622BHEP

Ipc: A23L 33/125 20160101AFI20200622BHEP

Ipc: A61K 31/702 20060101ALI20200622BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230922

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20240203